The co-expression of functional gastric proteins in dynamic gastric diseases and its clinical significance

BMC Clinical Pathology

Volumn 13, Issue 1, 2013, Pages

  Li, Ping ^a   Xu, Qian ^a   Sun, Li Ping ^a   Wang, Ben Gang ^a   Liu, Jing Wei ^a   He, Cai Yun ^a   Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Functional proteins; Gastric cancer; Immunohistochemistry; Mucin1(MUC1); Mucin2 (MUC2); Pepsinogen C(PGC)

Indexed keywords

MUCIN 1; MUCIN 2; PEPSINOGEN II;

ADULT; ARTICLE; ATROPHIC GASTRITIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUCOSA CELL; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CANCER; SUPERFICIAL GASTRITIS;

EID: 84881165717     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-13-21     Document Type: Article

References (40)

1. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI, Gastroenterology 1982 83 1 Pt 2 204 209 7084603 (Pubitemid 12121596)
2. Molecular cloning of neonate/infant-specific pepsinogens from rat stomach mucosa and their expressional change during development. Kageyama T, Ichinose M, Tsukada-Kato S, Omata M, Narita Y, Moriyama A, Yonezawa S, Biochem Biophys Res Commun 2000 267 3 806 812 10.1006/bbrc.1999.2047 10673373 (Pubitemid 30099405)
3. The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, Janciauskas D, Kiudelis G, Chiu HM, Lin JT, Dig Dis Sci 2009 54 11 2377 2384 10.1007/s10620-009-0947-5 19731026
4. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China. Sun LP, Gong YH, Wang L, Yuan Y, World J Gastroenterol 2007 13 48 6562 6567 10.3748/wjg.13.6562 18161928
5. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Broutet N, Plebani M, Sakarovitch C, Sipponen P, Megraud F, Br J Cancer 2003 88 8 1239 1247 10.1038/sj.bjc.6600877 12698190 (Pubitemid 36606340)
6. Mucins and mucin binding proteins in colorectal cancer. Byrd JC, Bresalier RS, Cancer Metastasis Rev 2004 23 1-2 77 99 15000151 (Pubitemid 38221597)
7. Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells. Julian J, Carson DD, Biochem Biophys Res Commun 2002 293 4 1183 1190 10.1016/S0006-291X(02)00352-2 12054500 (Pubitemid 34681066)
8. Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin. Macao B, Johansson DG, Hansson GC, Hard T, Nat Struct Mol Biol 2006 13 1 71 76 10.1038/nsmb1035 16369486 (Pubitemid 43049405)
9. Overexpression and altered glycosylation of MUC1 in malignant mesothelioma. Creaney J, Segal A, Sterrett G, Platten MA, Baker E, Murch AR, Nowak AK, Robinson BW, Millward MJ, Br J Cancer 2008 98 9 1562 1569 10.1038/sj.bjc.6604340 18454162 (Pubitemid 351652333)
10. Cell surface-associated mucins in signal transduction. Singh PK, Hollingsworth MA, Trends Cell Biol 2006 16 9 467 476 10.1016/j.tcb.2006.07.006 16904320 (Pubitemid 44293402)
11. Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Ren J, Agata N, Chen D, Li Y, Yu WH, Huang L, Raina D, Chen W, Kharbanda S, Kufe D, Cancer Cell 2004 5 2 163 175 10.1016/S1535-6108(04) 00020-0 14998492 (Pubitemid 38283802)
12. MUC1* mediates the growth of human pluripotent stem cells. Hikita ST, Kosik KS, Clegg DO, Bamdad C, PLoS One 2008 3 10 3312 10.1371/journal.pone. 0003312 18833326
13. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, Tanaka S, Irimura T, Kim YS, Sato E, Clin Cancer Res 1998 4 11 2605 2614 9829723 (Pubitemid 28523486)
14. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH, Cancer 2001 92 6 1427 1434 10.1002/1097-0142(20010915)92:6<1427::AID- CNCR1466>3.0.CO;2-L 11745219 (Pubitemid 32947826)
15. Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors. Mejias-Luque R, Linden SK, Garrido M, Tye H, Najdovska M, Jenkins BJ, Iglesias M, Ernst M, de-Bolos C, Oncogene 2010 29 12 1753 1762 10.1038/onc.2009.467 20062084
16. Helicobacter pylori eradication prevents extension of intestinalization even in the high-risk group for gastric cancer. Shiotani A, Nishi R, Uedo N, Iishi H, Tsutsui H, Ishii M, Imamura H, Kamada T, Hata J, Haruma K, Digestion 2010 81 4 223 230 10.1159/000264651 20110706
17. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells. Matsuda K, Yamauchi K, Matsumoto T, Sano K, Yamaoka Y, Ota H, Scand J Gastroenterol 2008 43 1 25 33 10.1080/ 00365520701579795 18938748
18. The relation of pepsinogen group II (PGII) expression to intestinal metaplasia and gastric cancer. Stemmermann GN, Nomura AM, Histopathology 2006 49 1 45 51 10.1111/j.1365-2559.2006.02446.x 16842245 (Pubitemid 43972919)
19. Expression and prognostic significance of pepsinogen C in gastric carcinoma. Fernandez R, Vizoso F, Rodriguez JC, Merino AM, Gonzalez LO, Quintela I, Andicoechea A, Truan N, Diez MC, Ann Surg Oncol 2000 7 7 508 514 10.1007/s10434-000-0508-9 10947019 (Pubitemid 30666490)
20. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas. Barresi V, Vitarelli E, Grosso M, Tuccari G, Barresi G, Eur J Histochem 2006 50 4 301 309 17213039 (Pubitemid 351480092)
21. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance. Zhang HK, Zhang QM, Zhao TH, Li YY, Yi YF, World J Gastroenterol 2004 10 20 3044 3047 15378790
22. MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis. Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Inokuchi S, et al. Oncol Rep 2001 8 3 485 489 11295067 (Pubitemid 33758441)
23. Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases. Ning PF, Liu HJ, Yuan Y, World J Gastroenterol 2005 11 17 2545 2548 15849808 (Pubitemid 40704267)
24. Risk of gastric cancer is associated with the MUC1 568 A/G polymorphism. Xu Q, Yuan Y, Sun LP, Gong YH, Xu Y, Yu XW, Dong NN, Lin GD, Smith PN, Li RW, Int J Oncol 2009 35 6 1313 1320 19885554
25. Dynamic changes of mucin MUC2 in gastric diseases and its significance. Xu Q, Wang B, Sun L, Li P, Yuan Y, J Surg Concepts & Pract 2011 16 3 252 255 23930886
26. Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins. Byrd JC, Ho JJ, Lamport DT, Ho SB, Siddiki B, Huang J, Yan PS, Kim YS, Cancer Res 1991 51 3 1026 1033 1988113
27. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Taylor-Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL, Bodmer WF, Int J Cancer 1981 28 1 17 21 10.1002/ijc.2910280104 7309278 (Pubitemid 11070004)
28. Rise and fall of an anti-MUC1 specific antibody. Thie H, Toleikis L, Li J, von-Wasielewski R, Bastert G, Schirrmann T, Esteves IT, Behrens CK, Fournes B, Fournier N, et al. PLoS One 2011 6 1 15921 10.1371/journal.pone.0015921 21264246
29. Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential. Berchuck A, Soisson AP, Clarke-Pearson DL, Soper JT, Boyer CM, Kinney RB, McCarty KS Jr, Bast RC Jr, Cancer Res 1989 49 8 2091 2095 2702650 (Pubitemid 19106520)
30. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. Wakatsuki K, Yamada Y, Narikiyo M, Ueno M, Takayama T, Tamaki H, Miki K, Matsumoto S, Enomoto K, Yokotani T, et al. J Surg Oncol 2008 98 2 124 129 10.1002/jso.21093 18521835
31. Superficially elevated-type serrated hyperplastic lesion of the stomach with minute adenocarcinoma. Hasuo T, Semba S, Satake S, Shirasaka D, Aoyama N, Yokozaki H, Dig Endosc 2009 21 2 101 105 10.1111/j.1443-1661.2009.00831.x 19691783
32. Characteristics of gastric and intestinal mucin phenotypes of gastric carcinoma. Mabuchi N, Niwa Y, Hirooka Y, Ohmiya N, Itoh A, Maeda O, Ando T, Goto H, Hepatogastroenterology 2008 55 88 2277 2281 19260522
33. Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer. Nakamura J, Kitajima Y, Kai K, Hashiguchi K, Hiraki M, Noshiro H, Miyazaki K, Am J Pathol 2011 178 2 515 524 10.1016/j.ajpath.2010.10.010 21281785
34. Mucinous gastric carcinomas: clinicopathologic and molecular analyses. Choi JS, Kim MA, Lee HE, Lee HS, Kim WH, Cancer 2009 115 15 3581 3590 10.1002/cncr.24422 19479974
35. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. Senapati S, Chaturvedi P, Sharma P, Venkatraman G, Meza JL, El-Rifai W, Roy HK, Batra SK, Br J Cancer 2008 99 6 949 956 10.1038/sj.bjc.6604632 18781152
36. Evaluation of pepsinogen A expression in stomach cancer]. Shumakov AR, Fedorov SN, Kalinovskii VP, Khanson KP, Vopr Onkologii 1999 45 3 238 240
37. Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas. Gurbuz Y, Kloppel G, Virchows Arch 2004 444 6 536 541 15071739 (Pubitemid 38858377)
38. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. Leung WK, Yu J, Chan FK, To KF, Chan MW, Ebert MP, Ng EK, Chung SC, Malfertheiner P, Sung JJ, J Pathol 2002 197 5 582 588 10.1002/path.1147 12210076
39. Expression of TFF1, TFF2 and TFF3 in gastric cancer. Kirikoshi H, Katoh M, Int J Oncol 2002 21 3 655 659 12168114
40. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simoes M, J Pathol 2000 190 4 437 443 10.1002/(SICI)1096-9896(200003) 190:4<437::AID-PATH547>3.0.CO;2-1 10699992 (Pubitemid 30163583)